Rhumbline Advisers Brainsway Ltd. Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Brainsway Ltd. stock. As of the latest transaction made, Rhumbline Advisers holds 18,077 shares of BWAY stock, worth $189,808. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,077
Previous 16,382
10.35%
Holding current value
$189,808
Previous $86,000
26.74%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BWAY
# of Institutions
29Shares Held
3.04MCall Options Held
0Put Options Held
0-
Masters Capital Management LLC Atlanta, GA900KShares$9.45 Million0.31% of portfolio
-
Essex Investment Management CO LLC Boston, MA348KShares$3.65 Million0.6% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA298KShares$3.13 Million0.46% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny277KShares$2.91 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA260KShares$2.73 Million0.0% of portfolio
About Brainsway Ltd.
- Ticker BWAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,519,200
- Market Cap $173M
- Description
- Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...